Genomic Vision (GV.PA) Stock Cash Flow
Europe - Euronext Paris - EPA:GV - FR0011799907 - Common Stock
0.0018 EUR
+0 (+5.88%)
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.62M | -6.79M | -4.97M | -5.18M | -4.61M | |||
| Depreciation Amortization | 1.24M | 686.00K | 231.00K | 589.00K | 78.00K | |||
| Change In Working Capital | 1.88M | 806.00K | 17.00K | 923.00K | -603.00K | |||
| Other non cash items | 2.09M | 888.00K | 204.00K | N/A | 7.00K | |||
| OPERATING CASH FLOW | -5.42M | -4.41M | -4.52M | -3.67M | -5.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -362.00K | -102.00K | -99.00K | -144.00K | -12.00K | |||
| Other Investing Activity | -147.00K | -167.00K | 73.00K | N/A | -14.00K | |||
| INVESTING CASH FLOW | -509.00K | -269.00K | -26.00K | -144.00K | -26.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 5.15M | 3.32M | -141.00K | -316.00K | -300.00K | |||
| Stock Issued/Repurchased | 15.00K | 3.00K | 4.98M | 5.03M | 3.36M | |||
| Other Financing Activity | -162.00K | -171.00K | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 4.95M | 3.15M | 4.84M | 4.72M | 3.06M | |||
| CHANGE IN CASH | -970.00K | -1.53M | 296.00K | 908.00K | -2.09M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.42M | -4.41M | -4.52M | -3.67M | -5.13M | |||
| Capital Expenditure | -362.00K | -102.00K | -99.00K | -144.00K | -12.00K | |||
| FREE CASH FLOW | -5.78M | -4.51M | -4.62M | -3.81M | -5.14M | |||
All data in EUR